| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |